Evelo Biosciences

Developer of therapeutics to treat a range of inflammatory diseases, COVID-19, and cancer

placeCambridge, Massachusetts, United States calendar_todayFounded 2015 groups117 employees language evelobio.com

Registered entities

Investor mix

8 investors on record; lead investors include Flagship Pioneering, Google Ventures, Celgene, Acks; 1 has since exited.

Investor typeCountShare
Venture capital563%
Bank & private debt113%
Other / undisclosed225%
Coming soon